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I n i t ia t ion  o f  In fec t ion  
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Linda Stowring, and Richard M. Locksley 
From the Departments of Medicine and Microbiology~Immunology, University of California, 
San Francisco, San Francisc~ California 94143 
Summary 
Leishmania major are intramacrophage parasites whose eradication requires the induction of T 
helper I (Thl) effector cells capable of activating macrophages to a microbicidal state. Interlenkin 
12 (IL-12) has been recently identified as a macrophage-derived cytokine capable of mediating 
Thl effector call development, and of markedly enhancing interferon 3' (IFN-3') production by 
T cells and natural killer cells. Infection of macrophages in vitro by promastigotes ofL. major 
caused no induction of IL-12 p40 transcripts, whereas timulation using heat-killed Listeria or 
bacterial lipopolysaccharide induced readily detectable IL-12 mRNA. Using a competitor construct 
to quantitate a number of transcripts, akinetic analysis of cytokine induction during the first 
few days of infection by L. major was performed. All strains of mice examined, including susceptible 
BALB/c and resistant C57BL/6, B10.D2, and C3H/HeN, had the appearance of a CD4 + 
population in the draining lymph nodes that contained transcripts for IL-2, IL-4, and IFN-3' 
(and in some cases, IL-10) that peaked 4 d after infection. In resistant mice, the transcripts for 
IL-2, IL-4, and IL-10 were subsequently downregulated, whereas in susceptible BALB/c mice, 
these transcripts were only slightly decreased, and IL-4 continued to be reexpressed at high levels. 
IL-12 transcripts were first detected in vivo by 7 d after infection, consistent with induction 
by intracellular amastigotes. Challenge of macrophages in vitro confirmed that amastigotes, in
contrast o promastigotes, induced IL-12 p40 mKNA. Reexamination f the cytokine mRNA 
at 4 d revealed expression of IL-13 in all strains analyzed, suggesting that IL-2 and IL-13 may 
mediate the IL-12-independent production of IFN-3' during the first days after infection. Leishmania 
have volved to avoid inducing IL-12 from host macrophages during transmission from the insect 
vector, and cause a striking induction of mRNAs for IL-2, IL-4, IL-10, and IL-13 in CD4 + 
T cells. Each of these activities may favor survival of the organism. 
T he resistance or susceptibility of inbred strains of mice to Le~hmania major correlates with the induction of 
parasite-specific Thl or Th2 responses, respectively (1-4). Sus- 
ceptibility is not related to the absence of precursors capable 
of parasite-specific Thl development, however, since a number 
of immunologic nterventions enables uch mice to heal and 
develop rotective Thl cells (5-9). Such interventions must 
be given within the first week of infection in order that redirec- 
tion of the CD4 subset response can be accomplished; inter- 
ventions at later times are unsuccessful. These studies ug- 
gest a critical early period after infection in which Thl or 
Th2 effector subsets become stablished. 
Although several experimental systems uggest arole for 
the type of APCs (10) or MHC dass lI haplotypes (11) in 
the developmental regulation of Thl or Th2 cells, recent data 
using limiting dilution analysis (12) and transgenic TCR mice 
(13, 14) suggest that cytokines themselves may be the most 
significant determinants in the maturation of CD4 + 
precursors to Thl or Th2 phenotypes. An extensive analysis 
of CD4 + T cells responding during the course of L. major 
infection was consistent with this model. Immunodominant 
CD4 + cells of both the Thl and Th2 phenotype used com- 
parable TCILs, consistent with their evolution from common 
precursors (15). This analysis suggests hat the cytokine milieu 
that occurs during the initial 1-2 wk after infection plays 
a major ole in shaping the subsequent development ofpro- 
tective Thl or noncurative Th2 cells. In vitro studies have 
identified a potentially important role for IL-12 (16, 17) in 
mediating Thl cell development. Indeed, treatment of sus- 
ceptible BALB/c mice with recombinant IL-12 mediates cure 
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in these animals associated with the production of Thl-like 
cytokines (18, 19), and neutralization of IL-12 leads to an 
adverse outcome in resistant mice (19). This effect may be 
mediated through induction of IFN-3' (18), and can be nega- 
tively regulated by IL-10 (13). Although neutralization of 
IFN-'), impedes the development ofcure (8, 20), IFN-~/itself 
is not capable of mediating sustained Thl cell development 
in susceptible mice (8, 21). IL-4 has been implicated in Th2 
development (13, 14, 16, 22-24) and inhibition of Thl de- 
velopment (25) in in vitro studies. Neutralization of IL-4 in 
infected BALB/2 mice induces curative Thl cell development 
(8). IL-2 is required for IL-4 production (24, 26), and neu- 
tralization of IL-2 was also capable of reversing susceptibility 
in the L. major model (27). It should be noted that these 
responses are specific to L. major; infection of BALB/c mice 
with Candida albicans leads to the development ofprotective 
Thl responses (28). 
Based on these considerations, we undertook a detailed anal- 
),sis of the cytokine response after the interaction of L. major 
with its host cell, the macrophage, in vitro, and during the 
early periods after infection in vivo. Rather than rely on re- 
stimulation of bulk lymphoo/tes in vitro (29) or analysis of 
limiting dilution assays (30, 31), we have employed a system 
of competitive quantitative r verse transcriptase-PCR ( T- 
PCR) (32) to analyze the cytokine response in defined cell 
populations after parasite challenge. This method has allowed 
us to identify, several novel features of the immunopathogen- 
esis of murine leishmaniasis and to delineate the critical in- 
tervals during which the Thl/Th2 switch occurs in this model. 
Matcriah and Methods 
Animals and Parasites. 6-8-wk-old BALB/c, C57BL/6, B10.D2, 
C3H/HeN, and C.B-17/scid (SCID) mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME) and housed in the Univer- 
sity of California, San Francisco (UCSF)animal futility. Infections 
were performed with promastigotes ofL. major (strain WHOM/ 
IR/-/173) grown in M199 media (UCSF Cell Culture Facility) 
supplemented with 30% fetal bovine serum and antibiotics. Metacy- 
clic organisms were isolated by negative selection after incubation 
of stationary-phase cultures with peanut lectin-coated beads (Sigma 
Chemical Co., St. Louis, MO) as described (33). In designated ex- 
periments, log-phase procyclic organisms were collected after 48 h 
of culture. Animal experiments u ed only metacyclics, which rep- 
resent he mature infectious tage of the promastigotes (34, 35). 
Animals were injected with 5 x 10 s organisms into each hind 
footpad in groups of three-to-five mice for each experimental point. 
Groups of coinfected BALB/c mice were maintained beyond the 
early time points of analysis to establish the virulence of the in- 
ocula. Control groups of animals received sham injections using 
the same volume of balanced salt solution. Designated mice were 
treated with mAb GK1.5 (anti-CD4) at the time of infection as 
described (7). Amastigotes were purified after disruption of footpad 
tissues from 6-wk-infeaed BALB/c mice and centrifugation through 
a Percoll gradient (Pharmacia, Inc., Piscataway, NJ) as described (7). 
Macrophages and Cell Lines. Bone marrow macrophages were 
established as described (36). Briefly, femurs from BALB/c and 
C57BL/6 mice were isolated and the marrow evacuated using a 
1-ml tuberculin syringe and 27-gange needle filled with balanced 
salt solution. Cells were grown in complete DME H21 (UCSF 
Cell Culture Facility) containing L cell-conditioned media (30% 
vol/vol), antibiotics, and 10% FCS (Hyclone Laboratories, Logan, 
LIT) for I wk until uniform monolayers ofmacrophages were es- 
tablished. After washing, stimuli were added at the following con- 
centrations: metacyclic or procyclic L. major, 2-20 organisms per 
macrophage; amastigotes, 1-10 organisms per macrophage, LPS 
(Escherichia coli 055:B5; Sigma Chemical Co.), 50 ng/ml; heat-killed 
Listeria monocytogenes (HKLM) 1, 108 CFU equivalents/m1. After 
6 or 24 h, monolayers were washed with warm balanced salt solu- 
tion, and the cells were removed from the wells by flushing with 
RNAzol (Biotecx, Houston, TX). 
Collection of Cells and Tissue. At designated periods after infec- 
tion, the popliteal LN and footpads were flash frozen in liquid 
nitrogen, pulverized to a fine powder, and placed in RNAzol. For 
analysis of cell subsets, popliteal LN were excised, teased to single 
cell suspensions, and incubated with designated mAbs against 
CD4 + (GK1.5; Becton-Dickinson & Co., Mountain View, CA), 
CD8 + (YTS 169.4; Caltag Laboratories, San Francisco, CA), or 
NKI.1 (PK 136; Pharmingen, San Diego, CA). Ceils were selected 
in a magnetic field using the appropriate s condary mAbs coupled 
to ferrous beads (Advanced Magnetics, Inc., Cambridge, MA) as 
described (2). Isolations were carried out entirely at 4~ The pu- 
rity of the designated s ections exceeded 90% in all groups as as- 
sessed by FACS | analysis (Becton Dickinson & Co.) in select ex- 
periments. Selection by this method resulted in no induction of 
cytokine transcripts in resting lymphocyte populations. 
Competitive Quantitative RT-PCR. Total RNA was extracted 
using RNAzol according to the manufacturer's directions. Speci- 
mens were quantitated both by optical density readings and inten- 
sity ofethidium staining on agarose gels. Reverse transcription was 
performed using murine Moloney leukemia virus RT (GIBCO 
BRL, Bethesda, MD) and random hexamer primers (Promega, 
Madison, WI) as described (15, 32). PCR was performed using 
a multiple cytokine-containing competitive construct as described 
in detail dsewhere (32). Briefly, aliquots of eDNA were first assayed 
for levels of the constitutively expressed gene, hypoxanthine-guanine 
phosphoribosyltransferase (HPRT), by phcing equal concentrations 
of the competitor construct in each reaction and examining the 
ratio of competitor-to-wild-type band intensity after amplification 
with HPRT-specitic primers. At the number of cycles performed, 
this visual inspection could discern differences a small as 1.25-fold 
(32). Adjustments were made in the amount of expe~aental cDNAs 
needed to standardize the HPRT levels to comparable levels among 
all groups. These adjusted vohmes of eDNA were then used to 
quantitate cytokine levels using a fixed concentration of compet- 
itor in each reaction i  the presence ofthe cytokine-specific primers. 
The primers used for amplification were as described (32) with the 
addition of the following: macrophage inflammatory protein 
lo~ (MIP-lc~): 5~ 
3'-GGCATTCAGTTCCAGGTCAGTGA~ IL-13: 5'-CTTGCT- 
TGCCTTGGTGGTCTCGC; 3 '-GCAGTTTTGTTATAAAGT- 
~ T .  Cytokine analyses were repeated and the HPRT levels 
were reestablished at the end of each experiment to confirm their 
reprodudbility. In this assay, separation of the amplification prod- 
ucts after electrophoresis on a 2.5% ethidium-stained agarose gel 
allows the discrimination of the larger competitor construct from 
the unknown, wild-type cDNAs that migrate farther in the gel. 
For most experiments, he ~nces  in band intensities between 
the wild-type and competitor amplifications between groups allowed 
1 Abbreviations u ed in this paper: iNOS, inducible nitric oxide syathase; 
HKLM, heat-killed Listeria monocytogenes; HPR.T, hypoxanthine-guanine 
phosphoribosyl-tramferase; MIP-lot, macrophage inflammatory protein-lot. 
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ready qualitative discrimination of therelative rnKNA leveh. In 
selected experiments, including the kinetic analyses, precise quanti- 
tation was achieved using standard titrations of thecompetitor against 
a constant cDNA input and used to normalize transcript levels to 
expression i resting tissues (32). 
Results 
Leishmania major Promastigotes Evade Induction of Macmphage 
Cytokines In Vitra Leishmania invade and replicate only within 
macrophages in the host. Macrophages can serve as the source 
of cytokines uch as IL-10 and IL-12 that modulate the de- 
velopment of CD4 + subsets (13, 16). Bone marrow macro- 
phages from BALB/c and C57BL/6 mice were isolated and 
incubated for 24 h with metacyclic or procyclic promastigotes 
of L. major, heat-killed Listeria or LPS (Fig. 1). Both HKLM 
and LPS were potent inducers of mKNA for IL-10, IL-12 
(as assessed byupregulation of p40 subunit expression [37, 
38]), MIP-lot, TNF-ot, and inducible nitric oxide synthase 
(iNOS). In contrast, neither the metacyclic nor procyclic forms 
of L. major induced any of these mKNA from macrophages 
under these conditions, with the exception of small but con- 
sistent increases in TNF-c~. None of these stimuli induced 
the appearance of TGF-3 transcripts significantly above the 
resting level. Variation of the inocula of promastigotes such 
that 30-90% of macrophages were infected with multiple 
amastigote forms at the conclusion of the assay or earlier anal- 
),sis at 6 h after infection resulted in no differences in this 
pattern of cytokine transcription (data not shown). Similar 
results were obtained using the P388.D1 and J774 macro- 
phage cell lines (data not shown). 
Induction of Crtokine Gene Transcription by Leishmania In 
Viva Susceptible BALB/c and resistant C57BL/6 mice were 
infected in the hind footpads with metacyclic L. major pro- 
mastigotes and killed immediately or 2, 4, 7, or 14 d later. 
Analysis of cytokine mKNA levels in whole LN by quantita- 
tive RT-PCR revealed a highly stereotyped pattern (Fig. 2); 
no cytokines were induced at these periods after injection 
with balanced salt solution. Both strains of mice exhibited 
a burst of IL-2 and IL-4 mKNA between 2 and 4 days after 
infection. Peak levels of IL-4 mRNA were usually higher in 
BALB/c mice (up to 16-fold) than in C57BL/6 (up to eight- 
fold), but were comparable in some experiments at4 d. By 
7 d, there was a marked decline in IL-2 and IL-4 mRNA 
in both groups of mice, although the decline in IL-4 was 
consistently less in BALB/c. By 14 d, IL-4 mRNA levels were 
reestablished at high levels in the BALB/c mice, whereas ex- 
pression essentially returned to baseline levels in C57BL/6 
animals. IL-2 mRNA closely followed IL-4 mRNA levels 
in C57BL/6 mice. 
Figure 1. Induction of cytokine mKNA by Leishmania in host macro- 
phages. BALB/c and C57BL/6 bone marrow-derived macrophages were 
incubated for 24 h in media alone, or challenged with heat-killed Listeria 
(HKLM), bacterial lipopulysaccharide (LPS), or metacyclic or procyclic 
promastigotes of L. major. Monolayers were washed and the KNA purified 
and used for RT-PCR. The input cDNAs were adjusted to yield com- 
parable ratios of the competitor (upper band in each reaction) to wild-type 
(lower band in each reaction) intensities in the amplification reaction for 
the constitutively expressed product, I'IPRT (bottom), as resolved on a 2.5% 
ethidium-stained agarose gal. These input cDNAs were used in subse- 
quent RT-PCK reactions using the designated oligomers for cytokines or 
inducible nitric oxide synthase (/NOS). IL-12 transcripts represent the in- 
ducibh p40 component of IL-12. HPKT levels were assayed again at the 
conclusion of the e~periment to establish the reliability of the cDNA 
volumes. Results are representative of five comparable experiments. 
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Figure 2. Cytokine mRNA in the draining LN after infection with 
metacyclic L. major. BALB/c (top) and C57BL/6 (bottom) mice were killed 
at designated time points after infection and the dr~inlng LN mRNA levels 
for the designated cytokines were assayed using RT-PCR. The kinetics 
of transcriptional changes for each gem were expressed relative o the levels 
expressed in the LN of uninfected animals, that were assigned a value of 
one. The cDNA concentrations examined at each time point were stan- 
dardized by equalizing the HPRT mRNA levels. Note the vertical scale 
in the BALB/c group extends one order of magnitude higher than the 
C57BL/6 group. The results represent o e of two comparable experiments. 
Variations between replicates within each experiment were <10%. 
Levels of IFN-7 rose steadily in both groups, but the 
BALB/c mice consistently maintained an earlier rise as com- 
pared to a late sustained increase in resistant C57BL/6 mice. 
C57BL/6 mice had negligible increases in IFN-7 mKNA 
until 7 d after infection, coincident with the decrease in IL-4 
mlLNA. BALB/c mice displayed asteady incremental rise in 
IL-10 mRNA from days 4 through 14, whereas resistant 
C57BL/6 mice had reproducible downregulation of IL-10 
transcripts between 4 and 7 d, followed by a slow return to 
basdine, uninfected levels. 
The 11..-4 Burst at 4 d Is Characteristic ofthe Early Immune 
Response to L. major. To determine whether other resistant 
strains of mice exhibited the same induction of cytokines at 
4 d after infection, cytokine mP-,NA expression in infected 
BALB/c mice was compared to expression in infected 
C57BL/6, C3H/HeN, and B10.D2 strains (Fig. 3). All in- 
fected animals displayed aburst of IL-4 and IL-2 mKNA ex- 
pression at 4 d, with at least fivefold elevations in all resistant 
strains tested. IFN- 7 mRNA levels were more variable, with 
highest levels in BALB/c and C3H/HeN mice, and lowest 
levels in C57BL/6 animals. 
Origin of lL-2 and IL-4 mRNA in CD4 + Cells. To assess 
the contribution by T cells to these cytokine transcripts, SCID 
mice were infected with L. major and the draining LN popu- 
lations harvested at 4 d and used to examine cytokine mKNA 
levels (Fig. 4). BALB/c mice, congenic with SCID except 
for a portion of chromosome 12 (39), were analyzed concur- 
rently. As compared to infected BALB/c mice, SCID mice 
expressed no detectable transcripts for IL-2 or IL-4, had 
markedly decreased levels of IL-10 mKNA, and demonstrated 
slightly enhanced l vels of IFN-3' mKNA. These data were 
consistent with the interpretation that IL-2 and IL-4 were 
derived from T cells, IL-10 was derived primarily from T 
cells, and IFN-'), could be derived from a non-T cell com- 
partment, presumably NK calls, previously demonstrated to 
be an important source of IFN-3' in this disease (40). 
Figure 4. Cytokine mRNA in SCID 
mice infected with L. major. Groups of 
three BALB/c or congenic SCID mice 
were infected (/NF) with metacyclic 
L. major and the LN harvested after 4 d. 
After I,uri~tion of gNA, the de~gmted 
cytokine mKNAs were compared by ad- 
justing for comparable HPKT input, and 
compared to uninfected BALB/c (N). 
Resting levels of these mKNAs in SCID 
mice were comparable to the uninfected 
BALB/c group. 
To further delineate the T cell lineage for these cytokine 
transcripts, BALB/c mice were depleted of CD4 + T cells at 
the time of infection by treatment with mAb GK1.5 before 
harvesting the LN cells after 4 d of infection (Fig. 5). Treat- 
ment with anti-CD4 abolished cytokine transcripts for IL-2, 
IL-4, IL-10, and IFN-'),, suggesting that CD4 T cells are 
required for the expression of these mKNAs. To quantitate 
cytokine mKNA expression i  CD4 + T cells directly, these 
cells were purified from infected BALB/c and C57BL/6 mice 
using magnetic beads before purification o fmRNA and RT- 
PCR (Fig. 5). By this assay, CD4 + cells expressed all of 
these cytokine transcripts in both strains of mice, and were 
the major source of IL-2, IL-4, and IL-10. Although CD4 § 
T cells contributed mRNA for IFN-% the major source of 
these transcripts occurred in the CD4- population of LN 
ceils. This population was identified in infected C57BL/6 
mice as cells expressing the NKI.1 marker by magnetic bead 
selection of CD4 +, CD8 +, and NKI,1 § ceils before mRNA 
purification and RT-PCK for IFN-% By this analysis, IFN-3~ 
expression was greatest in NKI.1 § cells, less in CD4 + calls, 
and least in CD8 + cells (data not shown). 
By 14 d after infection, purification of CD4 + T cells re- 
vealed substantial polarization of cytokine transcripts between 
susceptible BALB/c and resistant C57BL/6 mice, with devated 
IL-4 and IL-10 consistently present in BALB/c cells and devated 
IFN-7 present in C57BL/6 ceils (15, and data not shown). 
Figure 3. Cytokine mRNA in susceptible and resistant mice. Popliteal 
LN from groups of three from naive (N) and infected (/) animals of the 
designated strains were harvested 4 d after infection. Competitive PCK 
was performed for the designated cytokines after standardizing the cDNA 
concentration to the HPKT amplification signal. 
Figure 5. Cellular sources of 
the early cytokine burst in murine 
leishmaniam. Groups of five mice 
injected with L. major or bahnced 
mk solution (BSS) wt~e asmyed fiar 
mRNA for the designated cyto- 
kines 4 d after inoculation. The 
an/mah wetr divided into 
those pir with anti42D4 
mAb before harvest of the LN, 
and those whose LN cells were 
selected into CD4 § (R,'ILB~ or 
C57BL/6 [Ba']) or CD4-  
(BALB/c) populations using 
mAbs coupled to magnetic beads 
before mRNA ~traction. 
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Figure 6. Inducrionoflb12p40andIL-DmRNAafterinfectionwith 
L. major. Groups office BALB/c or C57BL/6 mice were inoculated with 
metacydic. L. major nd the LN harvested at the designated periods after 
infection. After isolation of mKNA, transcripts were analyzed for expres- 
sion of IL.12 p40 and IL-13 mKNA using RT-PCR. Results were com- 
parable in three separate experiments. 
In contrast to their distribution at 4 d, the IFN-3~ transcripts 
were contained predominantly in the CD4 + and not the 
CD4- compartment. 
Footpads were harvested at 2 and 4 d after infection to 
assess whether significant amounts of these cytokines could 
be detected at earlier periods at thesite of parasite inocula- 
tion. None of these transcripts were reliably detected at these 
early periods in tissue, and IL-4 mRNA did not appear at 
the footpad site until day 7 or later after infection in both 
resistant and susceptible mice (data not shown). 
Delayed Induction of IL-12 In Vivo Correlates with the Ap- 
pearance of Amastigotes, which Induce IL-I2 in Macmphages, In- 
vestigations ofinduction of IL-12 p40 transcripts in vivo were 
carried out in BALB/c, C57BL/6 and C3H/HeN mice. None 
had detectable induction of IL-12 p40 mtLNA at day 2 or 
4 after infection in 12 separate experiments. A typical experi- 
ment in BALB/c and C57BL/6 mice is shown (Fig. 6). Tran- 
scripts for IL-12 p40 first appeared b tween 7 and 14 d after 
infection, and were typically 10-fold higher in BALB/c as 
compared to C57BL/6 mice (data not shown). To test the 
sensitivity of the in vivo assay for detecting IL-12 p40 mRNA 
induction, BALB/c mice were either left untreated, or in- 
jected with either HLKM or L. major metacydic promastigotes 
(Fig. 7). Under these conditions, HKLM caused striking in- 
Figure 8. Amastigotes of 
L. major induce IL-12 p40 mRNA. 
Bone marrow-derived macro- 
phages were incubated for 24 h in 
media alone orwith a 10:1 ratio 
of L. major amastigotes or metacy- 
clic promastigotes, or with heat- 
kined L/ster/a (HKLM). RNA was 
purified and analyzed for induc- 
tion of IL-12 p40 mRNA as 
detailed in the legend to Fig. 1. 
Results represent one of three 
comparable experiments. 
duction of IL-12 p40 and IFN-~/mRNA, and, in contrast 
to L. major, suppressed transcripts for IL-4 below resting levds.
The delayed appearance of IL-12 transcripts in vivo, to- 
gether with prior reports demonstrating the capacity of an- 
tibodies to IL-12 to affect adversely the outcome of infection 
with L. major (19), suggested that tissue amastigotes might 
be responsible for inducing IL-12 p40 mRNA. Amastigotes 
were purified from infected footpad tissues and used to in- 
oculate bone marrow-derived macrophages in vitro. In con- 
trast o promastigotes, amastigotes induced IL-12 p40 tran- 
scripts in a manner comparable toHKLM (Fig. 8). Further, 
incubation of amastigotes, but not promastigotes, with SCID 
splenocytes induced the dose-dependent release of IFN-y 
(Reiner, S. L., and R. M. Locksley, unpublished observations), 
consistent with IL-12 protein release (41). 
IL-12 has been been identified as a major stimulus for IFN-'r 
production from NK cells (41-43). The absence of IL-12 in- 
duction by promastigotes raised questions regarding the 
stimulus for the induction of IFN-~/in the NK population 
before day 7 (40). IL-D is a recently described cytokine that, 
in human systems, has been demonstrated to induce the 
production of IFN-3' from NK cells both alone and syner- 
gistically with IL-2 (44). LN were isolated 4 d after infection 
from BALB/c, B10.D2, C57BL/6, and C3H/HeN mice, and 
examined for IL-13 transcripts using RT-PCK (Fig. 9). In 
each of these mice, IL-13 mRNA could be readily detected; 
peak expression occurred at 4 (Fig. 6). Examination of tran- 
scripts using mRNA purified from the CD4 + and CD4- 
cell populations in both infected BALB/c and C57BL/6 mice 
confirmed expression of IL-D mRNA in the CD4 + popu- 
lation at 4 d (data not shown). 
Figure 7. Inoculation of Le/shman/a or
heat-killed L/sto/a. Groups of three 
BALB/c mice were left uninfected (na/~), 
or were inoculated in the hind footpads 
with 107 CFU heat-killed Listeria mono- 
cytog~s (HK/.M) or metaqr.lic L. major, 
killed after 2 d and the popliteal LN cells 
e~amined for levels d Ib12 p40, IFN W 
and IL,4 mlLNA using RT-PCR stan- 
dardized to HPRT levels. 
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Figure 9. IL-13 mRNA is induced 
4 d after infection with L. major. 
Groups of five mice of the designated 
strains were either left uninfected 
(naive) or infected with metacydic 
L. major and the popliteal LN har- 
vested at 4 d for analysis of IL-13 
mRNA expression using RT-PCR 
standardized to HPtLT (data not 
shown). 
Discussion 
Leishmania re intramacrophage parasites whose survival 
requires evasion of CD4-mediated activation of macrophages 
to a microbicidal state. The major cytokine produced by 
CD4 + T cells mediating macrophage activation against 
Leishmania is IFN-% and neutralization of IFN-~/renders 
otherwise resistant mice unable to restrict he progression 
of disease (20). Recently, IL-12 has been implicated in medi- 
ating IFN-~/production by both T cells and NK ceils (43, 
45) and has been demonstrated to play a major role in the 
development ofThl effector CD4 cells (16, 17). As demon- 
strated here, Leishmania promastigotes evade induction of IL-12 
by macrophages in vitro and during infection in vivo, sug- 
gesting that this organism has evolved to enter macrophages 
using pathways that preclude the host's use of this important 
IFN-3,-inducing pathway. Additional cytoldnes produced by 
macrophages, including MIP-lc~ and IL-10, were similarly 
not induced by this organism, and TNF-~ was only minimally 
induced. Our inability to document the induction of tran- 
scripts for TGF-B suggests that the observed enhancement 
in TGF-/3 production reported by others (46) may reflect post- 
translational regulation. Metacyclic promastigotes of L. major 
enter macrophages primarily using the CR1 (CD35) receptor 
(47), suggesting that cross-linking of CR1 may not effec- 
tively trigger macrophage cytokine production. This is in 
contrast o organisms uch as Listeria or Toxoplasma (which 
use laminin-binding integrin receptors [48]), and the LPS of 
gram-negative organisms (which binds to CD14 [49] or CR3 
[50]), all of which induce IL-12 production from macrophages 
in vitro and in vivo (16, 45, 51). As demonstrated here, one 
consequence of the relatively "silent" entry utilized by Le/sh- 
mania was the failure to transcribe iNOS, an indispensable 
component of the priming of macrophages to an antileish- 
manial state (52, 53). 
Although recombinant IL-12 has been demonstrated to en- 
able susceptible BALB/c mice to heal L. major infection (18, 
19), the data presented here suggest hat failure to activate 
IL-12 transcription i  vivo does not underlie the genetic sus- 
ceptibility to L. major. IL-12 transcripts were first detected 
in all strains only seven or more days after infection. Impor- 
tantly, in resistant strains of mice, generation of IL-12 oc- 
curred at a time after IL-4 and IL-10 became dowuregnlated, 
thus leaving IFN-3' unimpeded in the activation of macro- 
phages. In contrast, susceptible BALB/c mice maintained 
significant levels of ILat and IL-10 during the period of IL-12 
induction, suggesting that IFN-~ produced in this period 
may be incapable of activating macrophages (54-57) or that 
the effects of IL-12 may be significantly attenuated (13). The 
capacity of 1L-12 to cure BALB/c mice (18, 19) and the failure 
of IFN-3, to cure (8), suggests that some of the effects of 
IL-12 may be IFN-3' independent. Similar conclusions have 
been generated in human systems of IL-4-mediated Ig class 
switching (58). 
The observation that polyclonal ntisera g, lmt IL-12 were 
capable of abrogating control of L major in resistant C57BL/6 
(19) suggests hat IL-12 induced after 7 d is required for max- 
imizing the host control of the parasite. In contrast to the 
promastigotes naturally inoculated by the sandfly vector, the 
tissue amastigotes induced readily detectable transcripts for 
IL-12 p40 when incubated with macrophages in vitro, and 
the appearance of IL-12 transcripts after infection in vivo cor- 
related with the period during which amastigotes rupture 
and spread from infected macrophages. The mechanisms by 
which amastigotes, a  opposed to promastigotes, induce IL-12 
remains unknown, although preliminary experiments sug- 
gest that the iipophosphoglycan surface antigen, LPG, of 
promastigotes inhibits the induction of II,-12 from stimu- 
lated macrophages (Reiner, S. L., and R. M. Locksley, un- 
published observations). Promastigotes ofLeishmania donovani 
were significantly more susceptible tomacrophage-mediated 
microbiddal ctivities than were amastigotes (59), suggesting 
that once transformation ccurs, amastigotes are more pre- 
pared for intracdhhr survival. Indeed, persistence of L. major 
amastigotes for prolonged Periods has been documented, even 
in resistant strains of mice (60, 61). 
In contrast to their elatively silent invasion of macrophages 
in vitro, Leishmania promastigotes induced broad, Th0-1ike 
(62) cytokine xpression i  CD4 § T ceils that peaked 4 d 
after infection. This was true in all strains of mice mined  
and occurred irrespective of healer or nonhealer phenotype. 
Although the patterns of cytokine induction were similar in 
these mice in over 15 experiments, quantitative differences 
between strains were consistently noted. This was particu- 
larly true for IFN-3, mRNA, for which C3H/HeN and 
BALB/c mice were consistently high producers, whereas 
C57BL/6 mice expressed low levels of this cytokine. These 
quantitative differences did not correlate with outcome of 
infection, however, suggesting that expression of IFN-~ 
mRNA at early periods after infection does not correlate with 
the healer or nonbealer phenotype. Differences in IFN-~ 
production presumably reflect differences in the NK com- 
partments between these strains of mice (40). 
The demonstration f induction of a reproducible Th0 
phenotype at4 d is consistent with the development ofThl 
and Th2 cells from a common precursor, as suggested by 
studies of TCK usage in L. major infection (15) and in modu- 
lation of CD4 subset development in cells from TCK trans- 
genic mice (13, 14). Earlier studies using different methods 
corroborate hese findings. Thus two laboratories have es- 
tablished the capacity to recover CD4 + T cells that produce 
both IL-4 and IFN~ within the first week after infection 
with L. major from both susceptible and resistant strains (30, 
31). These investigators used restimulation of isolated LN 
cells followed by limiting dilution analysis to recover secreted 
cytokines from supernatants generated invitro, and the hy- 
pothesis was advanced that the failure of BALB/c mice to 
cure correlated with a failure to downregulate the secretion 
of 1I,-4 (31). We have generated similar data using a tran- 
scriptional approach that avoids potential artifacts induced 
during restimulation in vitro when cells may be isolated from 
the natural mih'en. In contrast, our approach does not docu- 
ment he efficient translation and secretion of these cytokines. 
In agreement with the earlier studies, stimulation of lyre- 
452 Leishmania Evade I1.-12 Induction 
phocytes i olated 4 d after infection of both susceptible and 
resistant mice with the mitogen Con A yielded detectable 
IL-4 and IFN-3r by both ELISA and ELISPOT assays in both 
susceptible and resistant mice (Reiner, S. L., unpublished 
results). The cytokines expressed by T cells are regulated al- 
most entirely at the transcriptional level (63), and the pres- 
ence of sequences in the 3'-untranslated regions of these 
mKNAs confers hort half-lives on these pleiotropic medi- 
ators of the immune response (64). IL-12 is unusual among 
these cytokines in consisting of a heterodimer. The p35 subunit 
is constitutively expressed ina number of cell types, including 
macrophages (51), but is not efficiently secreted in the ab- 
sence of the p40 subunit (37). The latter is transcriptionally 
induced in macrophages by a number of stimuli and contains 
the typical 3'-untranslated cytokine sequences conferring short 
mKNA half-life (38, 65). No instances in which induction 
of p40 mRNA in macrophages has not resulted in secretion 
of bioactive p35/p40 IL-12 have been described (45). The cor- 
roboration of much of the findings using protein-based assays 
by the transcriptional pproach used here suggests the va- 
lidity of this experimental strategy, which has the advantage 
of examining increased numbers of cytokines due to the powers 
of a PCR-based approach. At the same time, some differ- 
ences are apparent in these studies. Whereas Morris et al. 
(30) could detect IL-4 from lymphocytes from C57BL/6 mice 
at 14 d after infection, we could detect little IL-4 mRNA 
in vivo during this period. Thus, some differences due to 
the experimental methodologies, the site of inoculation 
(footpads in this study versus base of the tail in the earlier 
study), or our use of selected metacyclic organisms, were ob- 
served. 
The most striking differences between susceptible and resis- 
tant mice in this analysis was the failure of susceptible BALB/c 
mice to downregulate ranscripts for IL-4 after their induc- 
tion 4 d after infection. In contrast, resistant mice down- 
regulated IL-4 transcripts to baseline, uninfected, levels by 
7-14 d after infection. Such downregulation left IFN-'y 
mRNA unopposed in resistant mice. These data suggest that 
a number of cytokine transcripts (IL-2, IL-4, and II.-10), with 
the notable xclusion of IFN-3,, have the capacity to be coor- 
dinately downregulated after their induction, and further sug- 
gest that BALB/c mice may have a defect in this regulatory 
pathway. Alternatively, BALB/c mice may appropriately down- 
regulate cytokine transcripts in an early Th0 population of 
ceils that is overtaken by an expanding population of Th2 
ceils between days 2 and 7. 
Two other features of the host response to L. major were 
noteworthy. First, CD4 + T ceils were the only source of 
IL-2 and IL-4, as assessed in studies of both SCID mice and 
CD4-depleted animals. Despite similar analysis of footpad 
tissues after infection, we were unable to document the early 
appearance of IL-4 at this site. This suggests that, as in 
influenza infection (66), the initial cytokine transcripts ap- 
pear in the draining regional LN and then subsequently are 
apparent in tissues as sensitized T cells recirculate to the pri- 
mary site of antigenic inoculation. It is still possible that 
preformed IL-4, as may occur in human mast cells (67), may 
be released in tissues and contribute to the initial cytokine 
burst in the draining LN. Further study will be required to 
address this possibility. Second, CD4 § T cells were required 
for the induction of IFN-3' transcripts, despite the observa- 
tion that the major source of IFN-3r mKNA was in the NK 
population. The evasion of IL-12 induction by promastigotes 
of Leishmania suggested alternative, T cell-dependent, 
pathways for IFN-3, production, as demonstrated by the dis- 
appearance of these transcripts after administration f anti- 
CD4 antibody. Studies using human peripheral blood cells 
stimulated with anti-CD3 and PHA have demonstrated that 
",'50% of the IFN-~ produced isdue to the endogenous pro- 
duction of IL-12 (45), thus confirming an IL-12-independent, 
T cell-dependent pathway for IFN-'y production. The ca- 
pacity of IL-D to synergistically enhance IFN-~/production 
from NK cells (44), and the demonstration f IL-13 in Th0 
clones (68), suggested that this cytokine may contribute to 
the induction of IFN-3r transcripts in the NK population, 
perhaps in conjunction with IL-2 (44), shortly after infec- 
tion with L. major. IL-13 mRNA could be readily detected 
in the CD4 + T cell population 4 d after infection in all 
strains of mice examined. Aside from its role in enhancing 
NK-derived IFN-% IL-13 most dosely resembles IL-4 in its 
activities (44, 68, 69), presumably because of its capacity to 
share components of the IL-4 receptor (70). Further evalua- 
tion of the role of IL-13 in IL-12-independent IFN-'), produc- 
tion will require the development of neutralizing antibodies 
to this recently described cytokine. 
In summary, these studies have elucidated several novel fea- 
tures elicited during the early periods after invasion by Leish- 
mania that may contribute to the survival of this parasite in 
host macrophages. First, Leishmania promastigotes enter mac- 
rophages by a pathway that evades the induction of cytokines 
implicated inorchestrating the cellular immune response, par- 
ticularly IL-12 (71). Second, a striking burst in IL-4 tran- 
scription occurs in the CD4 + T cell population that peaked 
at 4 d in all strains of mice analyzed. The simultaneous in- 
duction of IL-2, IL-10, IL-13, and IFN-3, in most strains ug- 
gests that a Th0 population has been stimulated. In contrast 
to resistant strains, susceptible BALB/c mice fail to down- 
regulate IL-4 transcription, an observation that may underlie 
the genetic susceptibility of this strain. Finally, amastigotes 
induce IL-12 from macrophages in a manner similar to other 
intracellular pathogens (16, 45, 51). Stage-specific evasion of 
IL-12 induction delays the development of Thl CD4 + T 
cells to allow transformation f the parasite to a developmental 
form more capable of withstanding the enhanced microbi- 
cidal systems of the activated macrophage. 
453 Reiner et al. 
We thank K. Dell and E Hatam for maintaining parasite cultures; A. Bistrup for constructing the IL-13 
competitor; and R. Seder for helpful discussions. 
This work was supported by grant AI-30663 from the National Institutes of Health. R. M. Locksley 
is a Burroughs Wellcome Fund Scholar in Molecular Parasitology. S. Zheng is a Sir Run Run Shaw Scholar 
at University of California, San Francisco. 
Address correspondence to Dr. Richard M. Locksley, University of California, San Francisco, 521 Par- 
nassus Avenue, Box 0654, Rm C-443, San Francisco, CA 94143-0654. 
Received for publication 14July 1993 and in reuised form 11 November 1993. 
~l~Fences 
1. Heinzel, F.P., M.D. Sadick, B.J. Holaday, R.L. Coffman, and 
R.M. Locksley. 1989. Reciprocal expression of interferon 
or interleukin 4 during the resolution or progression of mu- 
fine leishmaniasis. Evidence for expression of distinct helper 
T cell subsets. J EXl~ Med. 169:59. 
2. Heinzel, F.P., M.D. Sadick, S.S. Mutha, and R.M. Locksley. 
1991. Production of interferon % interleukin 2, interleukin 
4, and interleukin 10 by CD4 + lymphocytes in vivo during 
healing and progressive murine leishmaniasis. Proc. Natl. Acad. 
Sci. USA. 88:7011. 
3. Scott, P., P. Natovitz, R.L. Coffman, E. Pearce, and A. Sher. 
1988. Immunoregulation of cutaneous leishmaniasis. T cell lines 
that transfer protective immunity or exacerbation belong to 
different T helper subsets and respond to distinct parasite an- 
tigens. J. Extx Med. 168:1675. 
4. Boom, W.H., L. Liebster, A.K. Abbas, and R.G. Titus. 1990. 
Patterns of cytokine secretion i  murine leishmaniasis: corre- 
lation with disease progression or resolution. Infect. lmmun. 
58:3863. 
5. Howard, J.G., C. Hale, and F.Y. Liew. 1981. Immunological 
regulation of experimental cutaneous leishmaniasis. IV. Pro- 
phylactic effect of sublethal irradiation as a result of abroga- 
tion of suppressor T cell generation i  mice genetically sus- 
ceptible to Leishmania tropica, j. Extx Med. 153:557. 
6. Titus, R.G., R. Ceredig, J.-C. Cerottini, andJ.A. Louis. 1985. 
Therapeutic effect of anti-L3T4 monoclonal ntibody GK1.5 
on cutaneous leishmaniasis in genetically susceptible BALB/c 
mice. J. Immunol. 135:2108. 
7. Sadick, M.D., F.P. Heinzel, V.M. Shigekane, W.L. Fisher, and 
R.M. Locksley. 1987. Cellular and humoral immunity to Le/sh- 
mania major in genetically susceptible mice following in vivo 
depletion of L3T4 § cells. J. lmmunol. 139:1303. 
8. Sadick, M.D., EP. Heinzel, B.J. Holaday, R.T. Pu, R.S. 
Dawkins, and R.M. Locksley. 1990. Cure ofmurine leishman- 
iasis with anti-interleukin 4 monoclonal ntibody.J. Extx Med. 
171:115. 
9. Chatelain, R., K. Varkila, and R.L. Coffman. 1992. II,-4 in- 
duces a Th2 response inLeishmania major-infected mice.J, lm- 
munol. 148:1182. 
10. Gajewski, T.F., M. Pinnas, T. Wong, and F.W. Fitch. 1991. 
Murine Thl and Th2 clones proliferate optimally in response 
to distinct antigen-presenting cell populations. J. lmmunol. 
146:1750. 
11. Murray, J.S., J. Madri, T. Pasqualini, and K. Bottomly. 1993. 
Functional CD4 T cell subset interplay in an intact immune 
system. J  Immunol. 150:4270. 
12. Rocken, M., J.-H. Saurat, and C. Hauser. 1992. A common 
precursor for CD4 + T ceils producing ID2 or Ib4. f Im- 
munol. 148:1031. 
13. Hsieh, C.-S., A.B. Heimberger, J.S. Gold, A. O'Garra, and 
K.M. Murphy. Differential regulation of T helper phenotype 
development byinterleukins 4 and 10 in an c~/~ T-ceil-receptor 
transgenic system. Proa Natl. Acad. Sci. USA. 89:6065. 
14. Seder, R.A., W.E. Paul, M.M. Davis, and B. Fazekas de St. 
Groth. 1992. The presence of interleukin 4 during in vitro 
priming determines the lymphokine-producing potential of 
CD4 § T ceils from T cell receptor transgenic mice. J. Exp. 
Med. 176:1091. 
15. Reiner, S.L., Z.E. Wang, F. Hatam, P. Scott, and R.M. Locks- 
ley. 1993. Thl and Th2 cell antigen receptors in experimental 
leishmaniasis. Science (Wash. DC). 259:1457. 
16. Hsieh, C.-S., S.E. Macatonia, C.S. Tripp, S.F. Wolf, A. O'Garra, 
and K.M. Murphy. 1993. Development ofThl CD4 + T cells 
through IL-12 produced by Listeria-induced macrophages. 
Science (Wash. DC). 260:547. 
17. Manetti, R., P. Parronchi, M.G. Giudizi, M.-P. Piccini, E. 
Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer 
cell stimulatory factor (interleukin 12 [IL-12]) induces T helper 
type 1 (Thl)-specific mmune responses and inhibits the devel- 
opment of llr Th cells. J. Exp. Med. 177:1199. 
18. Heinzel, EP., D.S. Schoenhant, R.M. Rerko, L.E. Rosser, and 
M.K. Gately. 1993. Recombinant interleukin 12 cures mice 
infected with Leishmania major, f Ext~ Med. 177:1505. 
19. Sypek, J.p., C.L. Chung, S.E.H. Mayor, J.M. Subramanyam, 
S.J. Goldman, D.S. Sieburth, S.F. Wolf, and R.G. Schaub. 1993. 
Resolution of cutaneous leishmaniasis: interleukin 12 initiates 
a protective T helper type 1 immune response. J. Exp. Med. 
177:1797. 
20. Belosevic, M., D.S. Hnbloom, P.H. van der Meide, M.V. Slayter, 
and C.A. Nacy. 1989. Administration of monoclonal anti- 
IFN-3, antibodies in vivo abrogates natural resistance of 
C3H/HeN mice to infection with Leishmania major.J. Immunol. 
143:266. 
21. Tobin, J.F., S.L. Reiner, F. Hatam, S. Zheng, C.L. Leptak, 
D.F. Wirth, and R.M. Locksley. 1993. Transfected Leishmania 
expressing biologically active IFN-'y. J. lmmunol. 150:5059. 
22. Abehsira-Amar, O., M. Gibert, M. Jolly, J. Theze, and D.L. 
Jankovic. 1992. IL-4 plays a dominant role in the differential 
development of Th0 into Thl and Th2 cells. J. Immunol. 
148:3820. 
23. Swain, S.L., A.D. Weinberg, M. English, and G. Huston. 1990. 
Ib4 directs the development of Th2-1ike helper effectors. J
Immunol. 145:3796. 
24. Le Gros, G., S.Z. Ben-Sasson, R. Seder, F.D. Finkelman, and 
454 Leishmania Evade IL-12 Induction 
W.E. Paul. 1990. Generation ofinterleukin 4 (ID4)-producing 
ceils in vivo and in vitro: Ib2 and IL-4 are required for in vitro 
generation of II.-4-producing cells. J. Ex F Med. 172:921. 
25. Tanaka, T., J. Hu-Li, R.A. Seder, B. pazekas de St. Groth, 
and W.E. Paul. 1993. Interleukin 4 suppresses interleukin 2
and interferon 3` production by naive T cells stimuhted by ac- 
cessory cell-dependent receptor engagement. Pro~ Natl. Acad. 
Sci. USA. 90:5914. 
26. Ben-Sasson, S.Z., G. Le Gros, D.H. Conrad, ED. Finkelman, 
and W.E. Paul. 1990. IL-4 production by T cells from naive 
donors. Ib2 is required for II.,4 production.J. Immunol. 145: 
1127. 
27. Heinzd, F.P., R.M. Rerko, E Hatam, and lL.M. Locksley. 1993. 
IL-2 is necessary for the progression of leishmaniasis in suscep- 
tible murine hosts. J. Immunol. 150:3924. 
28. Romani, L., A. Mencacci, E. Cenci, R. Spaccapelo, P.Mosci, 
P. Pusccetti, and E Bistoni. 1993. CD4 + subset expression i  
murine candidiasis. Th responses correlate directly with ge- 
netically determined susceptibility or vaccine-induced resistance. 
f Immunol. 150:925. 
29. Scott, P. 1991. IFN-3` moduhtes the early development of Thl 
and Th2 responses in a murine model of cutaneous leishmani- 
asis. f lmmunol. 147:3149. 
30. Morris, L., A.B. Troutt, E. Handman, and A. Kelso. 1992. 
Changes in the precursor frequencies of IL-4 and IFN-3` se- 
creting CD4 § cells with resolution of lesions in routine cu- 
taneous leishmaniasis, f Immunol. 149:2715. 
31. Moll, H., and M. Rollinghoff. 1990. Resistance to murine cu- 
taneous leishmaniasis mediated by Thl cells, but disease- 
promoting CD4 § cells are different from Th2 ceUs. Eur.J. Im- 
munol. 20:2067. 
32. Reiner, S.L., S. Zheng, D.B. Corry, and R.M. Locksley. 1993. 
Constructing polycompetitor cDNAs for quantitative PCR. 
f Immunol. Methods. 165:37. 
33. Sacks, D.L., and R.P. Da Silva. 1987. The generation of infec- 
tive stage Leishmania major promastigotes is associated with 
the cell-surface expression and release ofa devdopmentally regu- 
lated glycolipid. J  Immunol. 139:3099. 
34. McConviile, M.J., S.J. Turco, M.A.J. Ferguson, and D.L. Sacks. 
1992. Devdopmental modification of lipophosphoglyr.an during 
the differentiation fLeishmania major promastigotes to an in- 
fectious tage. EMBO (Fur. Mol. Biol. Organ.) f 11:3593. 
35. Pimenta, P.EP., S.J. Turco, M.J. McConville, P.G. Lawyer, P.V. 
Perkins, and D.L. Sacks. 1992. Stage-specific adhesion of Le/sh- 
mania promastigotes to the sandfly midgut. Science (Wash. DC). 
256:1812. 
36. Johnson, C.R.., D. Kitz, andJ.R. Little. 1983. A method for 
the derivation and continuous propagation of cloned murine 
bone marrow macrophages, f Immunol. Methods. 65:319. 
37. Gubler, U., A. O'Chua, D.S. Schoenhaut, C.M. Dwyer, W. 
McComas, IL. Motyka, N. Nabavi, A.G. Wolitzky, P.M. 
Quinn, PC. pamilletti, and M.K. Gately. 1991. Coexpression 
of two distinct genes is required to generate secreted bioactive 
cytotoxic lymphocyte maturation factor. Pro~ Natl. Acad. Sci. 
USA. 88:4143. 
38. Wolf, S.E, P.A. Temple, M. Kobayashi, D. Young, M. Dicig, 
L. Lowe, R. Dzialo, L. Fitz, C. Ferenz, R.M. Hewick, et al. 
1991. Cloning of eDNA for natural killer cell stimuhtory factor, 
a heterodimeric cytokine with multiple biologic effects on T 
and natural killer cells. J. Immunol. 146:3074. 
39. Ansell, J.D., and G.J. Bancroft. 1989. The biology of the SCID 
mutation. Immunol. Today. 10:322. 
40. Scharton, T.M., and P. Scott. 1993. Natural killer cells are a 
source of interferon 3, that drives differentiation f CD4 + T 
cell subsets and induces early resistance to Leishmania major 
in mice. J. Exl~ Med. 178:567. 
41. Tripp, C.S., S.E Wolf, and E.R. Unanue. 1993. Interleukin 
12 and tumor necrosis factor ot are costimulators ofinterferon 
3` production by natural killer cells in severe combined im- 
munodeficiency mice with listeriosis, and interleukin 10 is a 
physiological antagonist. Pro~ Natl. Acad. Sci. USA. 90:3725. 
42. Chan, S.H., M. I~bayashi, D. Santoll, R Perussia, and G. Trin- 
chieri. 1992. Mechanisms of IFN-3` induction by natural killer 
cell stimulatory factor (NKSF/IL-12). Role of transcription of
mRNA stability in the synergistic nteraction between NKSF 
and IL-2. J. lmmunol. 148:92. 
43. Chan, S.H., B. Perussia, J.W. Gupta, M. Kobayashi, M. Pospfsil, 
H.A. Young, S.F. Wolf, D. Young, S.C. Clark, and G. Trin- 
chieri. 1991. Induction of interferon 3' production by natural 
killer cell stimulatory factor: characterization of the responder 
cells and synergy with other inducers. J. EXl~ Med. 173:869. 
44. Minty, A., P. Chalon, J.-M. Derocq, X. Dumont, J.-C. 
Guillemot, M. Kaghad, C. Labit, P. Leplatois, P. Liauzun, B. 
Miloux, et al. 1993. Interleukin-13 isa new human lymphokine 
regulating inflammatory and immune responses. Nature (Lond.). 
362:248. 
45. D'Andrea, A., M. Rengaraju, N.M. Valiante, J. Chehimi, M. 
Kubin, M. Aste, S.H. Chart, M. Kobayashi, D. Young, E. Nick- 
barg, et al. 1992. Production of natural killer cell stimulatory 
factor (interleukin 12) by peripheral blood mononuchar cells. 
J. Extx Med. 176:1387. 
46. Barral-Netto, M., A. Barral, C.E. Brownell, Y.A.W. Skeiky, 
L.R. Ellingsworth, D.K. Twardzik, and S.G. Reed. 1992. Trans- 
forming growth factor-B in ldshmanial infection: a parasite 
escape mechanism. Science (Wash. DC). 257:545. 
47. Da Silva, K.P., B.E Hall, K.A. Joiner, and D.L. Sacks. 1989. 
CK1, the C3b receptor, mediates the binding of infective Le/sh- 
mania major metacyclic promastigotes to human macrophages. 
f Immunol. 143:617. 
48. Furtado, G., Y. Cao, and K.A. Joiner. 1992. Laminin on Toxo- 
plasma gondii mediates parasite binding to the fll integrin re- 
ceptor c~6B1 on human foreskin fibroblasts and Chinese ham- 
ster ovary cells. Infect. Immun. 60:4925. 
49. Wright, S.D., R.A. Ramos, P.S. Tobias, R.J. Ulevitch, and 
J.C. Mathison. 1990. CD14, a receptor for complexes of lipo- 
polysaccharide (LPS) and LPS binding protein. Science (Wash. 
DC). 249:1431. 
50. Wright, S.D., S.M. Levin, M.T.C. Jong, Z. Chad, and L.G. 
Kabbash. 1989. CR3 (CDllb/CD18) expresses one binding 
site for Arg-Gly-Asp-containing peptides and a second site for 
bacterial lipopolysaccharide. J. Ex F Med. 169:175. 
51. Gazzinelli, R.T., S. Hieny, T.A. Wynn, S. Wolf, and A. Sher. 
1993. Interleukin 12 is required for the T-lymphocyte-inde- 
pendent induction of interferon 3, by an intracellular parasite 
and induces resistance in T-cell-deficient hosts. Proa Natl. Acad. 
Sci. USA. 90:619. 
52. Liew, EY., S. Millot, C. Parkinson, R.M.J. Palmer, and S. Mon- 
cada. 1990. Macrophage killing of Leishmania parasite in vivo 
is mediated by nitric oxide from arginine.J. Immunol. 144:4794. 
53. Green, S.J., C.A. Nacy, and M.S. Meltzer. 1991. Cytokine- 
induced synthesis of nitrogen oxides in macrophages: a pro- 
tective host response to Leishmania nd other intracellular 
pathogens, f Leukocyte Biol. 50:93. 
54. Bodgan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage 
deactivation by interhukin 10. f Ex F Med. 174:1549. 
55. Oswald, I.P., T.A. Wynn, A. Sher, and S.L. James. 1992. In- 
455 Reiner et al. 
terleukin 10 inhibits macrophage microbicidal ctivity by 
blocking the endogenous production of tumor necrosis factor 
c~ required as a costimulatory factor for interferon 3,-induced 
activation. Proa Natl. Acad. Sci. USA. 89:8676. 
56. Oswald, I.P., R..T. Gazzinelli, A. Sher, and S.L. James. 1992. 
Ibl0 synergizes with 11.-4 and transforming growth factor-fl 
to inhibit macrophage cytotc~ic a tivity.f lmmu,ol. 148:3578. 
57. Lehn, M., WN. Weiser, S. Engerhorn, S. Gillis, and H.G. 
Remold. 1989. II,4 inhibits H2Oz production and antileish- 
manial capacity of human cultured monocytes mediated by 
IFN~. f Immu,ol. 143:3020. 
58. Kiniwa, M., M. Gately, U. Gubler, R. Chizzonite, C. Fargeas, 
and G. Delespesse. 1992. Recombinant i erleukin-12 suppresses 
the synthesis of immunoglobulin E by interleukin-4 stimu- 
lated human lymphocytes, f Clin. Invest. 90:262. 
59. Murray, H.W. 1982. Call-mediated immune response in ex- 
perimental visceral leishmaniasis. II. Oxygen-dependent killing 
of intracellular Leiskmania donovani amastigotes, f Iramunol. 
129:351. 
60. LeClerc, C., F. Modabber, F.Deriaud, and L. Chedid. 1981. 
Systemic infection of Leishmania tropica (major) in various trains 
of mice. Trans. Roy. So~ Trol~ Med. Hyg. 75:851. 
61. Aebischer, T., S.F. Moody, and E. Handman. 1993. Persistence 
of virulent Leiskmania major in murine cutaneous leishmani- 
asis: a possible hazard for the host. Infect. Immun. 61:220. 
62. Firestein, G.S., W.D. Roeder, J.A. Laxer, K.S. Townsend, C.T. 
Weaver, J.T. Hom, J. Linton, B.E. Torbett, and A.L. 
Ghsebrook. 1989. A new routine CD4 + T cell subset with 
an unrestricted cytokine profile. J lmmu,ol. 143:518. 
63. Brorson, K.A., B. Beverley, S.-M. Kang, M. Lenardo, and R.H. 
Schwartz. 1991. Transcriptional regulation of cytokine genes 
in nontransformed T cells, f Iramunol. 147:3601. 
64. Caput, D., B. Beutler, K. Hartog, R. Thayer, S. Brown-Shimer, 
and A. Cerami. 1986. Identification fa common ucleotide 
sequence in the Y-untranslated region of mRNA molecules 
spedfying inflammatory mediators. Proa Natl. Acad. Sci. USA. 
83:1670. 
65. Schoenhant, D.S., A.O. Chua, A.G. Wolitzky, P.M. Quinn, 
C.M. Dwyer, W. McComas, PC. FamiUetti, M.K. Gately, and 
U. Gubler. 1992. Cloning and expression fmurine Ib12. J. 
Imraunol. 148:3433. 
66. Carding, S.R., W. Allen, A. McMickle, and P.C. Doherty. 
1993. Activation of cytokine genes in T cells during primary 
and secondary murine influenza puenmonia.J. Exlx Med. 177: 
475. 
67. Bradding, P., I.H. Feather, P.H. Howarth, R. Mueller, J.A. 
Roberts, K. Britten, J.P.A. Bews, T.C. Hunt, Y. Okayama, 
C.H. Heusser, et al. 1992. Interleukin 4 is localized to and 
released by human mast cells. J. EXlX Med. 176:1381. 
68. McKenzie, A.N.J., J.A. Culpepper, R. de Waal Malefyt, F. 
Briere, J. Punnonen, G. Aversa, A. Sato, W. Dang, B.G. Cocks, 
S. Menon, et al. 1993. Interleukin 13, a T-cell-derived cytokine 
that regulates human monocyte and B-ceU function. Proa Natl. 
Acad. Sci. USA. 90:3735. 
69. Punnonen, J., G. Aversa, B.G. Cocks, A.N.J. McKenzie, S. 
Menon, G. Zurawski, K. de Waal Malefyt, and J.E. de Vries. 
1993. Interlenkin 13 induces interleukin 4-independent IgG4 
and IgE synthesis and CD23 expression in human B cells. Proc. 
Natl. Acad. Sci. USA. 90:3730. 
70. Zurawski, S.M., S. Vega, B. Huyghe, and G. Zurawski. 1993. 
Receptors for interlenkin-13 and interleukin-4 are complex and 
share anovel component that functions in signal transduction. 
EMBO (Fur. Mol. Biol. Organ.) J. 12:2663. 
71. Locksley, R.M. 1993. Interleukin 12 in host defense against 
microbial pathogens. Proa Natl. Acad. Sci. USA. 90:5879. 
456 Leishmania Evade I1.-12 Induction 
